OUR PRODUCTS

MOBILE APPS

GENERAL INFO

LMNL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Liminal BioSciences (LMNL) Ownership - Who owns Liminal BioSciences?

Liminal Biosciences Inc is a clinical stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using our drug discovery platform and a data driven approach... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

231 Dundas Street East

Phone

N/A

Employees

Web

https://www.liminalbiosciences.com

Details

Group

Domestic Stock Funds

Fundamentals

LMNL

Capitalization

N/A

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

N/A

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

N/A

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical corporation, which engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer

Industry Biotechnology